INTRODUCTION
Infection still remains a problem in the health sector in developing countries. The mortality rate of infection cases, particularly hospital-acquired infection, is still high. A common agent of hospital-acquired infection is Acinetobacter baumanii. The fatality rate of Acinetobacter infection is increasing due to multidrug-resistant strain infection. Multidrugresistant (MDR) strains emerged due to selective pressure antibiotic that mostly used in intensive care wards.
1
There have been few reports on the tendency change of A. baumanii sensitivity to antibiotics in Indonesia.
2- 4 The aim of this study is to describe the tendency of sensitivities and MDR patterns of A. baumanii in Sanglah hospital as tertiary referral hospital in Bali, Indonesia. This knowledge will help guide the selection of appropriate empirical treatment at a local level and to provide a benchmark for comparison at other sites in Indonesia and Asia. To the best of our knowledge, this study is the first to report on the antimicrobial susceptibility and MDR patterns of A. baumanii in a tertiary referral hospital in Indonesia.
MATERIAL AND METHODS
This study was conducted in Sanglah hospital, a tertiary referral hospital with 750 beds and a major healthcare hub for the eastern part of Indonesia. Data of Acinetobacter baumanii and its antimicrobial sensitivity test which routinely performed in Sanglah Hospital were gathered retrospectively from clinical specimens from patients in 2012 to 2014. The study has approved the Committee of Ethical Research of Udayana University/Sanglah General Hospital.
The A. baumanii was isolated from clinical specimens including blood, urine, sputum, cerebrospinal fluid (CSF) and other specimens (vitreous fluid, pleural fluid, synovial fluid, throat swab, feces). Specimens management for bacteriology culture based on the standard operating procedure of the Department of Microbiology of Sanglah Hospital based on Clinical Microbiology Procedure Handbook.
5
Identification of microorganism and antimicrobial sensitivity tests were conducted using the microdilution method by Vitek-2 Compact system according to the Clinical And Laboratory Standard Institute (CLSI).
6 MDR was defined as resistance to 3 or more antibiotic classes as follow: quinolones (ciprofloxacin or levofloxacin), extended-spectrum cephalosporins (cefotaxime, ceftazidime or cefepime), aminoglycosides (gentamycin or amikacin), and carbapenems (imipenem or meropenem).
7
Data was collected and analyzed by Microsoft Excel 2017 software in a descriptive manner. Calculations were presented in descriptive tabulations.
RESULTS
During this study, as many as 1,143 isolates of A. baumanii were collected from various specimens. The number of total A. baumanii isolated from the year 2012 to 2013 was increasing from a total of 252 isolates to 378 isolates. In 2014, the isolates from non-ICU ward increased significantly by almost 60%, while isolates obtained from ICU slightly decreased to 111 isolates ( Figure 1 ). Sanglah hospital has two ICU wards, for adult and neonates, and nine non-ICU wards.
Most of A. baumanii isolates obtained from ICU were collected from sputum during 2012-2014 (7.9%, 11.1%, and 7.0%, respectively). In 2012, isolates of A.baumanii from Non-ICU wards were mostly obtained from urine specimens (62%), while in 2013 and 2014 the isolates were mostly obtained from both sputum and urine ( Table 1) .
The antimicrobial susceptibility of A. baumanii showed a different pattern between ICU and non-ICU isolates. The susceptibility of a. baumanii isolates, from ICU and non-ICU wards to quinolones (ciprofloxacin and levofloxacin), carbapenems (imipenem and meropenem), and 3rd generation cephalosporins (cefotaxime and ceftazidime) were decreasing from 2012 to 2014. The susceptibility of isolates from ICU to cefepime, the fourth generation of cephalosporin, were 9%, 12%, and 8% in 2012, 2013, and 2014, respectively. Meanwhile, the susceptibility of isolates from non-ICU were 29%, 35%, 33% in 2012, 2013, and 2014, respectively. We observed high sensitivity of ICU isolates to amikacin in 2012 but it was decreasing to 24% and 23% in 2013 and 2014, respectively, while the sensitivity of non-ICU isolates to amikacin remained high throughout the years with an increase in 2014 to 63%.
The susceptibility pattern of A. baumanii to cotrimoxazole was increasing from 12% in 2012 to 32% in 2014 in isolates from ICU wards, and from 22% in 2012 to 46% in 2014 in isolates from non-ICU wards ( Table 2 ). The A. baumanii isolates, from both ICU and non-ICU wards, showed reduced susceptibility to other combination of antibiotics such as ampicillin-sulbactam, cefoperazone-sulbactam, and piperacillin-sulbactam. The susceptibility test to colistin was conducted in 2014. We found that all isolates remained sensitive to colistin ( Table 2) . 
ORIGINAL ARTICLE
In addition, we observed two kinds of MDR pattern on A. baumanii based on its sensitivity to carbapenem, carbapenem-resistant A. baumanii (CRAB) and carbapenem-sensitive A. baumanii (CSAB). All isolates of CRAB and CSAB were resistant to 3rd/4th generation cephalosporins, aztreonam, and aminoglycosides. Meanwhile, a few of CRAB and CSAB isolates were susceptible to cotrimoxazole, beta-lactams, and quinolones. About 87.5%, 80.1% and 78.4% isolates from ICU wards were identified as MDR A. baumanii in 2012, 2013 and 2014 respectively (Table 3) . In this study, sputum was the most specimen which A. baumanii isolated from both ICU and non-ICU wards. A. baumanii isolated from sputum is a significant cause of hospital-acquired pneumonia (HAP) or ventilator-acquired pneumonia (VAP).
2,3,8
Urine specimens from non-ICU wards in 2013 and 2014 showed an increasing number of A. baumanii isolates. It shows that A. baumanii can be one of the causes of nosocomial urinary tract infection since Sanglah Hospital is a tertiary referral hospital where some patients were on a longterm catheter. Decreasing susceptibilities of A. baumanii isolates to many classes of antibiotics like quinolones, cephalosporins, and carbapenems were possibly due to overuse antibiotics either as empirical or definitive therapy. Furthermore, most of the referred patients have used those kinds of antibiotic prior to hospital admission.
The low susceptibility of A. baumanii isolates from ICU to Amikacin during 2014 (23%) will make intensivist difficult to use that regiment since it is used as empirical therapy. Another study showed higher susceptibility of A. baumanii to amikacin from 65-73.5%.
2, 3 Dent 9 reported that 58% of isolates from ICU were susceptible to amikacin in which has a similar percentage of susceptibility with non-ICU isolates (55-63%). Meropenem was one of the most frequently used carbapenems with similarly reduced susceptibility during 2012-2014. The lowest number of isolates that susceptibility to meropenem was occurred in 2013 and became constant on the next following years. This result was different with surveillance conducted by Cucunawangsih showed a decrease of susceptibility to meropenem in 2014 followed by an increase in 2015.
2, 3 The availability and adherence to antibiotic guidelines in the hospital will affect the susceptibilities of bacteria to certain antibiotics.
The susceptibility to Co-trimoxazole in ICU and non-ICU isolates was low about 12-32% and 22-46%, respectively. Those numbers showed the tendency of increased susceptibility for three years of surveillance. The other study reported a moderate susceptibility to Co-trimoxazole, between 57.9-73.2%, from ICU isolate. This significant difference is due to different type of hospital.
3 Increasing sensitivity caused by limited used of cotrimoxazole in referral hospital is because Cotrimoxazole is only available in oral preparation in Indonesia. Colistin has shown 100% of sensitivity but this regiment is unavailable in Indonesia yet.
There are several patterns of MDR A. baumanii recovered from this study, which are categorized into CRAB and CSAB. The most likely pattern in CRAB group was resistance to all antibiotic classes used in this study. Meanwhile, in the CSAB group, the isolates were mostly still susceptible to beta-lactams and cotrimoxazole.
The surveillance of antimicrobial susceptibility pattern will help to determine empirical treatment in infection cases. The cutoff point of antimicrobial sensitivity can be used as a guidance empirical therapy is 80-90%. Our surveillance showed that the susceptibility of A. baumanii to most common antibiotics was decreasing to the point where no antibiotics were appropriate as an empirical therapy against A. baumanii infection due to low sensitivity to all antibiotics relative to the empirical therapy threshold.
CONCLUSION
Three years surveillance showed that the susceptibility of A. baumanii to most common antibiotics was decreasing. MDR A. baumanii was found to be resistant to all classes of common antibiotics mostly from ICU ward isolates.
